Aura Biosciences Inc (AURA)
9.58
-0.11
(-1.14%)
USD |
NASDAQ |
Sep 20, 16:00
9.26
-0.32
(-3.34%)
After-Hours: 20:00
Aura Biosciences Price to Book Value: 2.482 for Sept. 20, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 19, 2024 | 2.511 |
| September 18, 2024 | 2.474 |
| September 17, 2024 | 2.480 |
| September 16, 2024 | 2.583 |
| September 13, 2024 | 2.609 |
| September 12, 2024 | 2.537 |
| September 11, 2024 | 2.350 |
| September 10, 2024 | 2.337 |
| September 09, 2024 | 2.083 |
| September 06, 2024 | 2.016 |
| September 05, 2024 | 2.026 |
| September 04, 2024 | 1.992 |
| September 03, 2024 | 1.915 |
| August 30, 2024 | 2.060 |
| August 29, 2024 | 2.034 |
| August 28, 2024 | 2.003 |
| August 27, 2024 | 1.977 |
| August 26, 2024 | 2.008 |
| August 23, 2024 | 1.967 |
| August 22, 2024 | 1.915 |
| August 21, 2024 | 1.995 |
| August 20, 2024 | 1.970 |
| August 19, 2024 | 2.127 |
| August 16, 2024 | 2.042 |
| August 15, 2024 | 2.120 |
| Date | Value |
|---|---|
| August 14, 2024 | 2.016 |
| August 13, 2024 | 2.112 |
| August 12, 2024 | 2.065 |
| August 09, 2024 | 2.150 |
| August 08, 2024 | 2.195 |
| August 07, 2024 | 2.122 |
| August 06, 2024 | 2.288 |
| August 05, 2024 | 2.218 |
| August 02, 2024 | 2.393 |
| August 01, 2024 | 2.554 |
| July 31, 2024 | 2.644 |
| July 30, 2024 | 2.600 |
| July 29, 2024 | 2.577 |
| July 26, 2024 | 2.683 |
| July 25, 2024 | 2.660 |
| July 24, 2024 | 2.401 |
| July 23, 2024 | 2.445 |
| July 22, 2024 | 2.370 |
| July 19, 2024 | 2.245 |
| July 18, 2024 | 2.284 |
| July 17, 2024 | 2.388 |
| July 16, 2024 | 2.396 |
| July 15, 2024 | 2.328 |
| July 12, 2024 | 2.217 |
| July 11, 2024 | 2.144 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.549
Minimum
Mar 18 2024
4.612
Maximum
Aug 17 2022
2.639
Average
2.534
Median
Price to Book Value Benchmarks
| Fulcrum Therapeutics Inc | 0.7646 |
| Moderna Inc | 2.156 |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 15.33 |
| iBio Inc | 0.6625 |
Price to Book Value Related Metrics
| Price | 9.58 |
| Earnings Yield | -18.68% |
| Market Cap | 475.23M |